FONAR CORP (FONR)

US3444374058 - Common Stock

16.09  -0.18 (-1.11%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to FONR. FONR was compared to 192 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making FONR a very profitable company, without any liquidiy or solvency issues. FONR is valued correctly, but it does not seem to be growing.



7

1. Profitability

1.1 Basic Checks

In the past year FONR was profitable.
FONR had a positive operating cash flow in the past year.
FONR had positive earnings in each of the past 5 years.
Each year in the past 5 years FONR had a positive operating cash flow.

1.2 Ratios

The Return On Assets of FONR (6.01%) is better than 85.42% of its industry peers.
With a decent Return On Equity value of 7.42%, FONR is doing good in the industry, outperforming 79.69% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.37%, FONR belongs to the top of the industry, outperforming 85.94% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FONR is in line with the industry average of 8.50%.
Industry RankSector Rank
ROA 6.01%
ROE 7.42%
ROIC 7.37%
ROA(3y)5.11%
ROA(5y)6.07%
ROE(3y)6.76%
ROE(5y)7.76%
ROIC(3y)7.69%
ROIC(5y)8.74%

1.3 Margins

FONR's Profit Margin of 11.88% is amongst the best of the industry. FONR outperforms 88.02% of its industry peers.
FONR's Profit Margin has declined in the last couple of years.
The Operating Margin of FONR (17.68%) is better than 91.67% of its industry peers.
In the last couple of years the Operating Margin of FONR has declined.
FONR's Gross Margin of 45.67% is in line compared to the rest of the industry. FONR outperforms 41.15% of its industry peers.
In the last couple of years the Gross Margin of FONR has remained more or less at the same level.
Industry RankSector Rank
OM 17.68%
PM (TTM) 11.88%
GM 45.67%
OM growth 3Y-2.08%
OM growth 5Y-9.09%
PM growth 3Y-0.22%
PM growth 5Y-18.23%
GM growth 3Y-2.15%
GM growth 5Y-0.94%

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FONR is destroying value.
Compared to 1 year ago, FONR has less shares outstanding
The number of shares outstanding for FONR has been increased compared to 5 years ago.
FONR has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.10 indicates that FONR is not in any danger for bankruptcy at the moment.
FONR has a better Altman-Z score (3.10) than 67.19% of its industry peers.
FONR has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
FONR has a better Debt to FCF ratio (0.07) than 94.27% of its industry peers.
FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, FONR is in the better half of the industry, outperforming 67.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 3.1
ROIC/WACC0.73
WACC10.06%

2.3 Liquidity

FONR has a Current Ratio of 9.35. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
FONR's Current ratio of 9.35 is amongst the best of the industry. FONR outperforms 90.10% of its industry peers.
FONR has a Quick Ratio of 9.15. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
FONR's Quick ratio of 9.15 is amongst the best of the industry. FONR outperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 9.35
Quick Ratio 9.15

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.35% over the past year.
The earnings per share for FONR have been decreasing by -15.66% on average. This is quite bad
Looking at the last year, FONR shows a small growth in Revenue. The Revenue has grown by 5.78% in the last year.
FONR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.88% yearly.
EPS 1Y (TTM)49.35%
EPS 3Y4.04%
EPS 5Y-15.66%
EPS growth Q2Q69.11%
Revenue 1Y (TTM)5.78%
Revenue growth 3Y4.78%
Revenue growth 5Y3.88%
Revenue growth Q2Q4.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.19 indicates a reasonable valuation of FONR.
Based on the Price/Earnings ratio, FONR is valued cheaper than 97.40% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 24.84. FONR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.19
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FONR is valued cheaply inside the industry as 98.44% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, FONR is valued cheaply inside the industry as 97.40% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.86
EV/EBITDA 2.48

4.3 Compensation for Growth

The decent profitability rating of FONR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FONR!.
Industry RankSector Rank
Dividend Yield N/A

FONAR CORP

NASDAQ:FONR (4/29/2024, 3:30:01 PM)

16.09

-0.18 (-1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap107.96M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.19
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.01%
ROE 7.42%
ROCE
ROIC
ROICexc
ROICexgc
OM 17.68%
PM (TTM) 11.88%
GM 45.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 9.35
Quick Ratio 9.15
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)49.35%
EPS 3Y4.04%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.78%
Revenue growth 3Y4.78%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y